These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9464792)

  • 1. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules.
    Biassoni R; Pessino A; Malaspina A; Cantoni C; Bottino C; Sivori S; Moretta L; Moretta A
    Eur J Immunol; 1997 Dec; 27(12):3095-9. PubMed ID: 9464792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors.
    Kim J; Chwae YJ; Kim MY; Choi IH; Park JH; Kim SJ
    J Immunol; 1997 Oct; 159(8):3875-82. PubMed ID: 9378975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation.
    Bottino C; Sivori S; Vitale M; Cantoni C; Falco M; Pende D; Morelli L; Augugliaro R; Semenzato G; Biassoni R; Moretta L; Moretta A
    Eur J Immunol; 1996 Aug; 26(8):1816-24. PubMed ID: 8765026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes.
    Winter CC; Long EO
    J Immunol; 1997 May; 158(9):4026-8. PubMed ID: 9126959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A HLA-Cw6 specific single-chain antibody fragment (scFv) recognizing a natural killer cell receptor epitope.
    Marget M; Bohlsen D; Davarnia P; Yoo-Ott K; Kabelitz D; Skerra A; Steinmann J
    Mol Immunol; 2005 Mar; 42(5):643-9. PubMed ID: 15607823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule.
    Fan QR; Garboczi DN; Winter CC; Wagtmann N; Long EO; Wiley DC
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7178-83. PubMed ID: 8692965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
    Winter CC; Gumperz JE; Parham P; Long EO; Wagtmann N
    J Immunol; 1998 Jul; 161(2):571-7. PubMed ID: 9670929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.
    Moretta A; Sivori S; Vitale M; Pende D; Morelli L; Augugliaro R; Bottino C; Moretta L
    J Exp Med; 1995 Sep; 182(3):875-84. PubMed ID: 7650491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human natural killer cell inhibitory receptors bind to HLA class I molecules.
    Döhring C; Colonna M
    Eur J Immunol; 1996 Feb; 26(2):365-9. PubMed ID: 8617305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors.
    Valés-Gómez M; Reyburn HT; Erskine RA; Strominger J
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14326-31. PubMed ID: 9826699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors.
    Fan QR; Mosyak L; Winter CC; Wagtmann N; Long EO; Wiley DC
    Nature; 1997 Sep; 389(6646):96-100. PubMed ID: 9288975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
    Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
    Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells.
    Rajagopalan S; Winter CC; Wagtmann N; Long EO
    J Immunol; 1995 Nov; 155(9):4143-6. PubMed ID: 7594568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies with various reactivity to p58 killer inhibitory receptors.
    Shin JS; Shin EC; Kim J; Choi IH; Park JH; Kim SJ
    Hybridoma; 1999 Dec; 18(6):521-7. PubMed ID: 10626681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand.
    Boyington JC; Motyka SA; Schuck P; Brooks AG; Sun PD
    Nature; 2000 Jun; 405(6786):537-43. PubMed ID: 10850706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex.
    Fan QR; Long EO; Wiley DC
    Nat Immunol; 2001 May; 2(5):452-60. PubMed ID: 11323700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity.
    Rajagopalan S; Long EO
    J Exp Med; 1997 Apr; 185(8):1523-8. PubMed ID: 9126935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
    Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
    Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.